Julián A Gajón

5PUBLICATIONS
19CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAutoimmunityOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 22, 2026
From Sentinels to Soldiers: Tissue-Resident Cells for Next-Generation Immunotherapy.

|May 21, 2026
The resilient subset: cancer stem cells at the core of immunotherapy resistance.

|Dec 04, 2025
Wnt3a-expressing cancer stem cells impair CD8+ TRM function, contributing to immunotherapy resistance in Melanoma.

Julián A Gajón, Angel Juarez-Flores, Fatima Mendoza-Roldan

|Jul 29, 2025
Cytotoxic Molecules as Potential Biomarkers for Active and Inactive Systemic Lupus Erythematosus.

Paola Santana-Sánchez, Astrid Asminda Ramírez-Pérez, Paolo Alberti-Minutti

|Mar 11, 2023
Acral Melanoma Is Infiltrated with cDC1s and Functional Exhausted CD8 T Cells Similar to the Cutaneous Melanoma of Sun-Exposed Skin.

Saraí G De Leon-Rodríguez, Cristina Aguilar-Flores, Julián A Gajón

Pageof 1

Frequent Collaborators

3 joint publications

Samira Muñoz-Cruz

2 joint publications

Ezequiel M Fuentes-Pananá

2 joint publications

Laura C Bonifaz

2 joint publications

Fatima Mendoza-Roldan